SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — John Henry Holliday — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJohn Henry Holliday
Date of birth1851-08-14
IdentifiersMRN HR-NI007-SYN-TD; SSN (made up) 000-07-8153
Document date1873-05-19
AuthorMartin Beaumont, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Nausea, vomiting, and loose stools for two days during tuberculosis treatment. [S]

History of Present Illness

Mr. Holliday is a 21-year-old dentist with drug-susceptible cavitary pulmonary tuberculosis in the sixth week of the continuation phase of isoniazid and rifampin, given by video-observed therapy, and with a mild alcohol use disorder. Two days ago he developed nausea and loose stools, and he vomited twice yesterday; two coworkers at the dental office had a stomach illness last week. When he reported the nausea on his video call this morning, the health department nurse told him to hold today's doses, as his treatment plan instructs, and to be seen today with liver tests. He has no yellowing of the eyes or skin, no dark urine or pale stools, no pain under the right ribs, and no itching or rash. His cough has gone and he has had no fevers or night sweats. He has not missed any other dose. He told us that nine days ago, at a friend's birthday party, he drank about six whiskeys over an evening, the first time he has drunk heavily since starting treatment; he has not drunk since. He feels he let himself down but has no thoughts of suicide. [S]

ElementDetail
OnsetTwo days ago
LocationUpper abdomen and bowel
DurationTwo days
CharacterNausea, two vomits, and loose stools
SeverityMild to moderate; drinking fluids
TimingSixth week of the continuation phase
ContextCoworkers with a stomach illness; one evening of heavy drinking nine days ago
Modifying factorsToday's doses held on the nurse's advice
Associated signs and symptomsNo jaundice, dark urine, right upper abdominal pain, rash, or fever

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired with the illness; no fever or night sweats
EyesNegativeNo yellowing of the eyes; vision normal
RespiratoryNegativeNo cough, sputum, or breathlessness
GastrointestinalPositiveNausea, two vomits yesterday, and loose stools; no right upper abdominal pain, blood, or pale stools
GenitourinaryNegativeUrine orange from rifampin as expected, not dark brown
IntegumentaryNegativeNo jaundice, rash, or itching
NeurologicalNegativeNo numbness or tingling of the hands or feet
PsychiatricNegativeDisappointed about the party; no thoughts of suicide or self-harm

8 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Isoniazid 300 mg tablet, one tablet daily300 mg once daily by video-observed therapy with the health department, seven days a week, for six monthsOral route1873-02-12 to 1873-08-13completedS
Rifampin 300 mg capsules, two capsules (600 mg) daily600 mg once daily on an empty stomach by video-observed therapy with the health department, seven days a week, for six monthsOral route1873-02-12 to 1873-08-13completedS
Pyrazinamide 500 mg tablets, three tablets (1500 mg) daily1500 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phaseOral route1873-02-12 to 1873-04-08completedS
Ethambutol 400 mg tablets, three tablets (1200 mg) daily1200 mg once daily by video-observed therapy with the health department, seven days a week, until susceptibility results returnOral route1873-02-12 to 1873-03-10stoppedS
Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily50 mg once daily with isoniazidOral route1873-02-12 to 1873-08-13completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1873-05-19Body height178cmS
1873-05-19Body weight61.8kgS
1873-05-19Body mass index (BMI) [Ratio]19.5kg/m2S
1873-05-19Systolic blood pressure108mm[Hg]S
1873-05-19Diastolic blood pressure68mm[Hg]S
1873-05-19Heart rate98/minS
1873-05-19Respiratory rate16/minS
1873-05-19Body temperature37.4CelS
1873-05-19Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1873-05-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma64U/L7-56 U/LHighS
1873-05-19Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma58U/L10-40 U/LHighS
1873-05-19Bilirubin.total [Mass/volume] in Serum or Plasma0.9mg/dL0.1-1.2 mg/dLNormalS
1873-05-19Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma98U/L40-129 U/LNormalS
1873-05-19Total score [AUDIT-C]4{score}S

Physical Exam

Vital signs recorded on 1873-05-19; see the Vital Signs section. [S]

SystemFinding
GeneralTired but well-appearing; weight 61.8 kg, down 0.7 kg from the last visit
EyesNo scleral icterus
MouthMucous membranes slightly dry
RespiratoryClear; a few fine crackles at the right apex that clear with coughing
AbdomenSoft, mildly tender around the umbilicus; liver not enlarged or tender; no guarding
SkinNo jaundice or rash

Problems

ProblemClinical statusVerificationCodeProvenance
Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistanceactiveconfirmed A15.0S — Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic.
Alcohol use disorder, mild, with binge drinkingactiveconfirmed F10.10S — Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic.
Acute viral gastroenteritis during tuberculosis treatment, with a mild aminotransferase rise below the threshold for drug-induced liver injury; resolvedresolvedconfirmed A08.4S — Synthetic intercurrent illness chosen to teach the assessment of nausea on isoniazid and rifampin; it does not echo a documented illness.

Assessment and Plan

Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); An official ATS statement: hepatotoxicity of antituberculosis therapy (2006); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea (2017)

Follow-up: Health department nurse to confirm the restart on tomorrow's video call. Liver tests in two weeks. End-of-treatment visit in the summer. Next scheduled visit 1873-08-18: end-of-treatment review after six months. [S]